Treatment Considerations for Patients With Advanced Squamous Cell Carcinoma of the Lung
Author:
Funder
AstraZeneca
Jazz Pharmaceuticals
Boehringer Ingelheim
G1 Therapeutics
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference91 articles.
1. National Institute of Health (National Cancer Institute). Non-small cell lung cancer treatment (PDQ)–health professional version. Updated 2021. Available at: https://www.cancer.gov/types/lung/hp/non-small-cell-lung-treatment-pdq. Accessed: October 12, 2021.
2. Comprehensive genomic characterization of squamous cell lung cancers;Nature,2012
3. Squamousness: next-generation sequencing reveals shared molecular features across squamous tumor types;Schwaederle;Cell Cycle,2015
4. Next generation sequencing and genetic alterations in squamous cell lung carcinoma: where are we today?;Friedlaender;Front Oncol,2019
5. Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function;Choi;Ann Oncol,2017
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Identification of Novel Stemness-based Subtypes and Construction of a Prognostic Risk Model for Patients with Lung Squamous Cell Carcinoma;Current Stem Cell Research & Therapy;2024-04
2. Improvement of differential diagnosis of lung cancer by use of multiple protein tumor marker combinations;Tumor Biology;2024-01-23
3. Matched tissue and liquid biopsies for advanced non-small cell lung cancer patients A potentially indispensable complementary approach;Translational Oncology;2023-09
4. Characterization of stemness features and construction of a stemness subtype classifier to predict survival and treatment responses in lung squamous cell carcinoma;BMC Cancer;2023-06-08
5. Morphometric analysis of nuclear shape irregularity as a novel predictor of programmed death-ligand 1 expression in lung squamous cell carcinoma;Virchows Archiv;2023-05-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3